1169 related articles for article (PubMed ID: 15134967)
21. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
22. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
23. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.
Hoebeke P; De Caestecker K; Vande Walle J; Dehoorne J; Raes A; Verleyen P; Van Laecke E
J Urol; 2006 Jul; 176(1):328-30; discussion 330-1. PubMed ID: 16753434
[TBL] [Abstract][Full Text] [Related]
24. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
Kuo HC
Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
[TBL] [Abstract][Full Text] [Related]
25. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
Kuo HC
Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
[TBL] [Abstract][Full Text] [Related]
27. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
[TBL] [Abstract][Full Text] [Related]
28. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity].
Chenet A; Perrouin-Verbe B; Le Normand L; Labat JJ; Brunel P; Lefort M; Mathé JF
Ann Readapt Med Phys; 2007 Nov; 50(8):651-60. PubMed ID: 17490775
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
31. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
32. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
Sahai A; Dowson C; Khan MS; Dasgupta P;
Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
[TBL] [Abstract][Full Text] [Related]
33. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
Kuo HC
Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
[TBL] [Abstract][Full Text] [Related]
34. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.
Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P
J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414
[TBL] [Abstract][Full Text] [Related]
35. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.
Schulte-Baukloh H; Weiss C; Stolze T; Herholz J; Stürzebecher B; Miller K; Knispel HH
Eur Urol; 2005 Dec; 48(6):984-90; discussion 990. PubMed ID: 16126328
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study.
Werner M; Schmid DM; Schüssler B
Am J Obstet Gynecol; 2005 May; 192(5):1735-40. PubMed ID: 15902187
[TBL] [Abstract][Full Text] [Related]
37. [Botulinum toxin type A in patients with overactive bladder].
Krivoborodov GG; Vasil'ev AV; Shumilo DV; Ivanov AV; Tur EI
Urologiia; 2010; (3):36-40. PubMed ID: 20734876
[TBL] [Abstract][Full Text] [Related]
38. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
Kuo HC
Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases.
Do Ngoc Thanh C; Audry G; Forin V
J Pediatr Urol; 2009 Dec; 5(6):430-6. PubMed ID: 19577520
[TBL] [Abstract][Full Text] [Related]
40. Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years.
Stoehrer M; Wolff A; Kramer G; Steiner R; Lmöchner-Ernst D; Leuth D; Steude U; Ruebben H
Urol Int; 2009; 83(4):379-85. PubMed ID: 19996642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
